Holding(s) in Company
March 27 2009 - 11:57AM
UK Regulatory
TIDMTED
RNS Number : 6454P
Tepnel Life Sciences PLC
27 March 2009
Tepnel Life Sciences Plc ("the Company")
Holding in Company
The Company was informed on the 26 March 2009, that following the acquisition of
Ordinary Shares on 24 March 2009 by Credit Suisse Group ('CSG'), CSG has a
notifiable interest of 22,170,000 ordinary shares in the Company, representing
approximately 8.68% of the issued share capital of the Company.
For further information:
Tepnel Life Sciences plc
Ben Matzilevich, Chief Executive Officer
Michael Slater, Group Finance Director
Carol Smith, Group Marketing Communications Manager
Tel: 0161 946 2200
Capital MS&L
Mary Clark or Joanna Whineray
Tel: +44 20 7307 5330
Seymour Pierce Limited
Mark Percy
Tom Sheldon
Christopher Wren
Tel: +44 20 7107 8000
Notes to Editors:
About Tepnel Life Sciences plc
Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences
products and services Group with two divisions, Molecular Diagnostics and
Research Products & Services. The Company has laboratories, manufacturing and
operations in the USA, UK and France with over 200 employees. Tepnel provides
test kits, reagents and services to two highly synergistic markets, these being
Molecular Diagnostics and Biomedical Research. The Company's strategy has been
to identify high growth niche opportunities within these multi-billion pound
markets. Tepnel focuses on these niche operations with internally developed
products, patents, expertise and know-how as well as strategic acquisitions, to
develop a leadership position within these
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUBVVRKSROUAR
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024